12th Mar 2018 07:00
e-Therapeutics plc
("e-Therapeutics" or the "Company")
Notification of Full Year Results Date
Oxford, UK - 12 March 2018 - e-Therapeutics plc (AIM: ETX), a company using Network-Driven Drug Discovery (NDD) to create new and better drugs, will announce its full year results for the year ended 31 January 2018 on Tuesday, 27 March 2018.
-Ends-
For more information, please contact:
e-Therapeutics plc Raymond Barlow, CEO Steve Medlicott, Finance Director
| Tel: +44 (0)1993 883 125 www.etherapeutics.co.uk
|
Numis Securities Limited Michael Meade / Freddie Barnfield (Corporate Finance) James Black (Corporate Broking)
| Tel: +44 (0) 207 260 1000 www.numis.com
|
Instinctif Partners Melanie Toyne Sewell / Alex Shaw / Deborah Bell | Tel: +44 (0) 207 457 2020 Email: [email protected] |
About e-Therapeutics plc
e-Therapeutics is an Oxford-based company with a unique and powerful computer-based drug discovery platform and a specialised approach to network biology.
Its novel methodology and Discovery Engine allow the Company to discover new and better drugs in a more efficient and effective way.
For more information about the Company, please visit www.etherapeutics.co.uk
Related Shares:
ETX.L